NCI advisors approve seven concepts at joint NCAB/BSA meeting

Conversation with The Cancer Letter Real-world Evidence

RWD company documents baseline trends in women’s cancers before Trump’s policy changes

The U.S. Supreme Court’s June 2022 decision to overturn Roe v. Wade has implications that reach far beyond access to reproductive health care services in the 41 states that ban or restrict access to abortion.

January 24, 2025

Vol.51 No.03

By Claire Marie Porter

White House

Rooting out the “illegal and immoral discrimination” of DEI is the first order of business for Trump

Surprised was the last thing anyone should claim to be as the Trump administration, on its first day, smashed the federal government’s diversity equity and inclusion offices, literally sending employees who administer these programs packing and making plans for their prompt firing.

Beyond the $500B Stargate Project: The frontier of AI in oncology beckons

On Jan. 21, President Donald Trump announced the launch of the Stargate Project, a $500 billion artificial intelligence infrastructure project designed to revolutionize healthcare.

January 24, 2025

Vol.51 No.03

By Sorena Nadaf-Rahrov

Obituary

Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.

Feng’s team advanced the understanding of biomarkers in prostate cancer

The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.

January 24, 2025

Vol.51 No.03

By NRG Staff

City of Hope: Making a profound difference as we pursue cancer cures at the speed of life

I am pleased to begin a new series from City of Hope, one of the largest and most advanced cancer research and treatment organizations in the U.S. With our National Medical Center ranking among the top 5 for cancer by U.S. News & World Report, we are making a profound and lifesaving difference.xxx:more

January 24, 2025

Vol.51 No.03

By Marcel van den Brink

NCI advisors approve seven concepts at joint NCAB/BSA meeting

YOU MAY BE INTERESTED IN

RWD company documents baseline trends in women’s cancers before Trump’s policy changes

Rooting out the “illegal and immoral discrimination” of DEI is the first order of business for Trump

Beyond the $500B Stargate Project: The frontier of AI in oncology beckons

Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48

Feng’s team advanced the understanding of biomarkers in prostate cancer

City of Hope: Making a profound difference as we pursue cancer cures at the speed of life

Renew today!

Subscriber content

Never miss an issue!

Login